Sign In
test

Jared Gandy

Squadron Capital Management Llc

Assets Managed
$272.918M
Holdings
33
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
15.66%(2Q avg: 7.83%)
Sustained Growth
1 quarters

Portfolio positions

This chart displays the top 10 holdings in Squadron Capital Management Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 33 positions.

Assets under management

The assets under management (AUM) of Squadron Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 272.918M in assets, with a quarterly growth rate of 15.66% and a 2-quarter average growth rate of 7.83%. The portfolio is managed by Jared Gandy, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
RLMD
Relmada Therapeutics Inc
Recent Activity
Increased 26.49%
21.62%
$58.983M
8.475M shares@ $6.96 avg price
COGT
Cogent Biosciences Inc
Recent Activity
Increased 0.97%
11.11%
$30.311M
787,492 shares@ $38.49 avg price
KALV
Kalvista Pharmaceuticals Inc
Recent Activity
Increased 85.73%
9.59%
$26.171M
1.3M shares@ $20.13 avg price
KOD
Kodiak Sciences Inc
Recent Activity
Increased 30.27%
5.31%
$14.486M
380,000 shares@ $38.12 avg price
ABVX
Abivax Sa-adr
Recent Activity
Decreased -10.34%
5.31%
$14.476M
130,000 shares@ $111.35 avg price
EWTX
Edgewise Therapeutics Inc
Recent Activity
4.04%
$11.025M
350,000 shares@ $31.5 avg price
ZNTL
Zentalis Pharmaceuticals Inc
Recent Activity
New Position
3.46%
$9.433M↑ Call
4.031M shares@ $2.34 avg price
NKTR
Nektar Therapeutics
Recent Activity
New Position
3.3%
$8.994M
125,000 shares@ $71.95 avg price
ANL
Adlai Nortye Ltd-adr
Recent Activity
New Position
3.21%
$8.755M
1.265M shares@ $6.92 avg price
RLAY
Relay Therapeutics Inc
Recent Activity
New Position
3%
$8.184M↑ Call
822,500 shares@ $9.95 avg price

1-10 of 33